Irfan Asanagi received an award from the Sarcoma Foundation of America for the proposal “EWS-FLI1 triggered opportunistic de novo enhancer assembly activates potential cellular therapy targets in Ewing Sarcoma.” Congratulations!

Previous Next
Close
Test Caption
Test Description goes like this